PEREGRINE Trademark

Trademark Overview


On Monday, October 26, 2020, a trademark application was filed for PEREGRINE with the United States Patent and Trademark Office. The USPTO has given the PEREGRINE trademark a serial number of 79303095. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by SkylineDx B.V.. The PEREGRINE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purpose...

Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer

Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the field of science and research related thereto; scient...
peregrine

General Information


Serial Number79303095
Word MarkPEREGRINE
Filing DateMonday, October 26, 2020
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6641521
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Goods and ServicesMedical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely oncology; preparations for detecting mutation in human genes for medical purposes
Goods and ServicesMedical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
Goods and ServicesResearch and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the field of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 29, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 29, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSkylineDx B.V.
Party Type30 - Original Registrant
Legal Entity Type78 - NOT AVAILABLE
AddressNL

Party NameSkylineDx B.V.
Party Type20 - Owner at Publication
Legal Entity Type78 - NOT AVAILABLE
AddressNL

Party NameSkylineDx B.V.
Party Type10 - Original Applicant
Legal Entity Type78 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 22, 2022FINAL DISPOSITION PROCESSED
Sunday, May 15, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Sunday, January 2, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 23, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Sunday, August 22, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 4, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 4, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 25, 2021REFUSAL PROCESSED BY IB
Thursday, April 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 8, 2021REFUSAL PROCESSED BY MPU
Thursday, April 1, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 31, 2021NON-FINAL ACTION WRITTEN
Friday, March 26, 2021ASSIGNED TO EXAMINER
Tuesday, February 2, 2021APPLICATION FILING RECEIPT MAILED
Friday, January 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 28, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB